We are live on ! Find out more

309 hedge funds and large institutions have $2.52B invested in Neogen in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 112 increasing their positions, 103 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.66% more ownership

Funds ownership: 94.14%96.8% (+2.7%)

9% more repeat investments, than reductions

Existing positions increased: 112 | Existing positions reduced: 103

0% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 36

3% less funds holding

Funds holding: 317309 (-8)

20% less capital invested

Capital invested by funds: $3.15B → $2.52B (-$624M)

72% less call options, than puts

Call options by funds: $808K | Put options by funds: $2.9M

Holders
309
Holders Change
-8
Holders Change %
-2.52%
% of All Funds
5.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
112
Reduced
103
Closed
36
Calls
$808K
Puts
$2.9M
Net Calls
-$2.09M
Net Calls Change
+$51K

NEOG Hedge Fund Activity: Q2 2022 in Review

309 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Neogen (NEOG) for Q2 2022, worth a combined $2.52B — down 20% from $3.15B a quarter earlier.

Fund positioning in NEOG was balanced in Q2 2022: 36 funds opened new positions, 36 closed out, 112 added to existing stakes and 103 trimmed.

The largest buyer was Select Equity Group, adding an estimated $49.7M. The largest seller was Brown Capital Management, cutting an estimated $44.5M.

  • 309 institutional investors held Neogen (NEOG) as of Q2 2022, down from 317 in Q1 2022.
  • Funds reported $2.52B of Neogen stock for Q2 2022, down 20% quarter-over-quarter.
  • 36 funds opened new Neogen positions in Q2 2022 and 36 closed out, a net change of 0 holders.
  • The largest Neogen buyer in Q2 2022 was Select Equity Group, an estimated $49.7M added.
  • The largest Neogen seller in Q2 2022 was Brown Capital Management, an estimated $44.5M sold.

Based on aggregated 13F filings for Q2 2022.